Insider Trades of FLYNN JAMES E Information

Click on the column header to resort ascending (▲) or descending (▼).

Individual Insider Trades

Company Relation Last Date Type Tran OwnerType Shares Traded ▼ Last Price Shares Held
NIVALIS THERAPEUTICS, INC. Beneficial Owner (10%) 06/23/2015 Form 4 Acquisition (Non Open Market) indirect 3,078,394 0 1,019,945
CAS MEDICAL SYSTEMS INC Beneficial Owner (10%) 01/01/2015 Form 4 Buy indirect 1,443,200 1.65 3,200,000
CAS MEDICAL SYSTEMS INC Beneficial Owner (10%) 01/01/2015 Form 4 Sell indirect 1,443,200 1.65 3,200,000
DICERNA PHARMACEUTICALS INC Beneficial Owner (10%) 02/04/2014 Form 4 Acquisition (Non Open Market) indirect 1,428,569 0 972,642
AVALANCHE BIOTECHNOLOGIES, INC. Beneficial Owner (10%) 08/05/2014 Form 4 Buy indirect 1,334,467 17 2,197,679
LOXO ONCOLOGY, INC. Beneficial Owner (10%) 08/06/2014 Form 4 Buy indirect 1,089,656 13 1,591,546
TRIVASCULAR TECHNOLOGIES, INC. Beneficial Owner (10%) 04/22/2014 Form 4 Buy indirect 1,065,000 11.9651 1,697,669
DICERNA PHARMACEUTICALS INC Beneficial Owner (10%) 02/04/2014 Form 4 Buy indirect 1,000,000 15 2,428,569
EHEALTH, INC. Beneficial Owner (10%) 01/14/2015 Form 4 Buy indirect 1,000,000 19.835 3,264,588
AVALANCHE BIOTECHNOLOGIES, INC. Beneficial Owner (10%) 08/05/2014 Form 4 Acquisition (Non Open Market) indirect 863,212 0 531,208
STEADYMED LTD. Beneficial Owner (10%) 03/25/2015 Form 4 Buy indirect 737,555 8.5 1,267,733
PROTEON THERAPEUTICS INC Beneficial Owner (10%) 10/27/2014 Form 4 Buy indirect 691,713 10 1,255,107
TRIVASCULAR TECHNOLOGIES, INC. Beneficial Owner (10%) 04/22/2014 Form 4 Acquisition (Non Open Market) indirect 632,669 0 253,384
ANTARES PHARMA, INC. Beneficial Owner (10%) 06/30/2015 Form 4 Sell indirect 608,691 2.0773 3,388,846
PROTEON THERAPEUTICS INC Beneficial Owner (10%) 10/27/2014 Form 4 Acquisition (Non Open Market) indirect 563,394 0 406,896
STEADYMED LTD. Beneficial Owner (10%) 03/25/2015 Form 4 Acquisition (Non Open Market) indirect 530,178 0 265,089
LOXO ONCOLOGY, INC. Beneficial Owner (10%) 08/06/2014 Form 4 Acquisition (Non Open Market) indirect 501,890 0 279,051
ATYR PHARMA INC Beneficial Owner (10%) 05/12/2015 Form 4 Acquisition (Non Open Market) indirect 461,528 0 230,764
ANTARES PHARMA, INC. Beneficial Owner (10%) 07/08/2015 Form 4 Sell indirect 444,341 2.045 14,122,602
NEOS THERAPEUTICS, INC. Beneficial Owner (10%) 07/28/2015 Form 4 Acquisition (Non Open Market) indirect 416,666 0 208,333